AGILE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3749 USD | 0.00% |
|
-0.74% | -80.77% |
| 05-15 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q1 Revenue $5.7M | MT |
| 03-28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AGILE THERAPEUTICS, INC. | Bio Therapeutic Drugs | 0.00% | -0.74% | -80.77% | -89.71% | -99.99% | 2.57M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AGRX Stock
- Charts Agile Therapeutics, Inc.
- Comparison Chart
